BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 28809447)

  • 1. Pulmonary delivery of tea tree oil-β-cyclodextrin inclusion complexes for the treatment of fungal and bacterial pneumonia.
    Li M; Zhu L; Zhang T; Liu B; Du L; Jin Y
    J Pharm Pharmacol; 2017 Nov; 69(11):1458-1467. PubMed ID: 28809447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tea tree oil nanoemulsions for inhalation therapies of bacterial and fungal pneumonia.
    Li M; Zhu L; Liu B; Du L; Jia X; Han L; Jin Y
    Colloids Surf B Biointerfaces; 2016 May; 141():408-416. PubMed ID: 26895502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhalable Andrographolide-β-cyclodextrin Inclusion Complexes for Treatment of Staphylococcus aureus Pneumonia by Regulating Immune Responses.
    Zhang T; Zhu L; Li M; Hu Y; Zhang E; Jiang Q; Han G; Jin Y
    Mol Pharm; 2017 May; 14(5):1718-1725. PubMed ID: 28378587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Encapsulation of tea tree oil by amorphous beta-cyclodextrin powder.
    Shrestha M; Ho TM; Bhandari BR
    Food Chem; 2017 Apr; 221():1474-1483. PubMed ID: 27979118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo activity of terpinen-4-ol, the main bioactive component of Melaleuca alternifolia Cheel (tea tree) oil against azole-susceptible and -resistant human pathogenic Candida species.
    Mondello F; De Bernardis F; Girolamo A; Cassone A; Salvatore G
    BMC Infect Dis; 2006 Nov; 6():158. PubMed ID: 17083732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of inhalable hyaluronan/mannitol composite dry powders for flucytosine repositioning in local therapy of lung infections.
    Costabile G; d'Angelo I; d'Emmanuele di Villa Bianca R; Mitidieri E; Pompili B; Del Porto P; Leoni L; Visca P; Miro A; Quaglia F; Imperi F; Sorrentino R; Ungaro F
    J Control Release; 2016 Sep; 238():80-91. PubMed ID: 27449745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo activity of tea tree oil against azole-susceptible and -resistant human pathogenic yeasts.
    Mondello F; De Bernardis F; Girolamo A; Salvatore G; Cassone A
    J Antimicrob Chemother; 2003 May; 51(5):1223-9. PubMed ID: 12668571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of tea tree oil (Melaleuca alternifolia) on fluconazole activity against fluconazole-resistant Candida albicans strains.
    Mertas A; Garbusińska A; Szliszka E; Jureczko A; Kowalska M; Król W
    Biomed Res Int; 2015; 2015():590470. PubMed ID: 25722982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The dynamics and mechanism of the antimicrobial activity of tea tree oil against bacteria and fungi.
    Li WR; Li HL; Shi QS; Sun TL; Xie XB; Song B; Huang XM
    Appl Microbiol Biotechnol; 2016 Oct; 100(20):8865-75. PubMed ID: 27388769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of tea tree oil 5%, tea tree oil 10%, and nystatin inhibition zones against vaginal Candida isolates in pregnancy.
    Ervianti E; Damayanti ; Purnamasari I; Astari L; Prasetyo B; Endraswari PD; Utomo B; Fitriani EW; Indramaya DM; Listiawan MY; Sigit Prakoeswa CR
    J Infect Dev Ctries; 2023 Mar; 17(3):353-358. PubMed ID: 37023426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma-treated poly(ethylene oxide) nanofibers containing tea tree oil/beta-cyclodextrin inclusion complex for antibacterial packaging.
    Cui H; Bai M; Lin L
    Carbohydr Polym; 2018 Jan; 179():360-369. PubMed ID: 29111062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of microdilution and disc diffusion methods in assessing the in vitro activity of fluconazole and Melaleuca alternifolia (tea tree) oil against vaginal Candida isolates.
    Ergin A; Arikan S
    J Chemother; 2002 Oct; 14(5):465-72. PubMed ID: 12462426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Influence of Tea Tree Oil on Antifungal Activity and Pharmaceutical Characteristics of Pluronic
    Wróblewska M; Szymańska E; Winnicka K
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of Melaleuca alternifolia (tea tree) oil on filamentous fungi and toxicity to human cells.
    Homeyer DC; Sanchez CJ; Mende K; Beckius ML; Murray CK; Wenke JC; Akers KS
    Med Mycol; 2015 Apr; 53(3):285-94. PubMed ID: 25631479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative evaluation of antifungal activity of melaleuca oil and fluconazole when incorporated in tissue conditioner: an in vitro study.
    Sharma S; Hegde V
    J Prosthodont; 2014 Jul; 23(5):367-73. PubMed ID: 24393097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Candida albicans Airway Colonization Facilitates Subsequent Acinetobacter baumannii Pneumonia in a Rat Model.
    Tan X; Chen R; Zhu S; Wang H; Yan D; Zhang X; Farmakiotis D; Mylonakis E
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3348-54. PubMed ID: 27001817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trypanocidal action of tea tree oil (Melaleuca alternifolia) against Trypanosoma evansi in vitro and in vivo used mice as experimental model.
    Baldissera MD; Da Silva AS; Oliveira CB; Santos RC; Vaucher RA; Raffin RP; Gomes P; Dambros MG; Miletti LC; Boligon AA; Athayde ML; Monteiro SG
    Exp Parasitol; 2014 Jun; 141():21-7. PubMed ID: 24657576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of tigecycline/colistin combination in a pneumonia model caused by extensively drug-resistant Acinetobacter baumannii.
    Mutlu Yilmaz E; Sunbul M; Aksoy A; Yilmaz H; Guney AK; Guvenc T
    Int J Antimicrob Agents; 2012 Oct; 40(4):332-6. PubMed ID: 22831842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical use of tea tree oil reduces the dermal absorption of benzoic acid and methiocarb.
    Nielsen JB; Nielsen F
    Arch Dermatol Res; 2006 Mar; 297(9):395-402. PubMed ID: 16315066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promising Antibacterial Effects of Silver Nanoparticle-Loaded Tea Tree Oil Nanoemulsion: a Synergistic Combination Against Resistance Threat.
    Najafi-Taher R; Ghaemi B; Kharrazi S; Rasoulikoohi S; Amani A
    AAPS PharmSciTech; 2018 Apr; 19(3):1133-1140. PubMed ID: 29218583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.